US Makes New Alzheimer’s Drug More Widely Accessible
[ad_1] Approximately 6.5 million Americans suffer from Alzheimer’s (Representational) The US drug regulator gave full approval to a new Alzheimer’s medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly. Leqembi, developed jointly by Japan’s Eisai and Biogen of the United States, was shown … Read more